Inventor

STATHAM ALEXIS S

US33 patents

⚠️ This page may combine multiple inventors who share the name “STATHAM ALEXIS S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STATHAM ALEXIS S

3M INNOVATIVE PROPERTIES CO

Reduction of IMIQUIMOD impurities at two months using refined oleic acid

Methods for reducing imiquimod impurities for two months, four months, and six months

Pharmaceutical creams with refined oleic acid

Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation (at least four months storage)

Reduction of imiquimod impurities at six months using refined oleic acid

Pharmaceutical creams with reduced imiquimod impurities

Methods for improving imiquimod availability at two months, four months and six months between refined and compendial

Methods for controlling formation of imiquimod impurities for two months, four months, and six months

Pharmaceutical cream with reduced imiquimod impurities at four months using refined oleic acid

Method of stabilizing imiquimod

Method of treating a mucosal and/or dermal associated condition

Method of inducing interferon biosynthesis

Immune response modifier formulations containing oleic acid and methods

Method of inducing cytokine biosynthesis

Method of treating actinic keratosis

Method of treating a dermal and/or mucosal associated condition

Reduction of imiquimod impurities in pharmaceutical creams

Method of treating genital or peri-anal warts

Pharmaceutical cream having similar or less levels of imiquimod impurity formation as cream with BHA (comparator)

Reduction of imiquimod impurities at four months using refined oleic acid

Reduction of imiquimod impurities using refined oleic acid

Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation

Methods for stabilizing imiquimod for two months, four months, and six months

Method of controlling formation of imiquimod impurities

Method of treating basal cell carcinoma

Method of treating mollescum contagiosum

Method of reducing imiquimod impurity formation

Antimicrobial disposable absorbent articles

STATHAM ALEXIS S

Immune response modifier formulations containing oleic acid and methods

Immune response modifier formulations containing oleic acid and methods

Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation

3M INNOVATIVE PROERTIES COMPANY

Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation

STOESZ JAMES D

Immune response modifier compositions and methods